Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment

BACKGROUND: Insulin degludec is a new-generation basal insulin with an ultra-long duration of action. We evaluated the pharmacokinetic properties of insulin degludec in subjects with normal renal function; mild, moderate or severe renal impairment; or end-stage renal disease (ESRD) undergoing hemodi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kiss, István, Arold, Gerhard, Roepstorff, Carsten, Bøttcher, Susanne Gammelgaard, Klim, Søren, Haahr, Hanne
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2013
Assuntos:
Original Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899495/
https://ncbi.nlm.nih.gov/pubmed/24163264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-013-0113-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares